⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MIST News
Milestone Pharmaceuticals Inc. Common Shares
Mistral Inc. Awarded U.S. Army Contract to Provide THOR Group 2 UAS Systems in Support of Company-Level Small UAS Needs
prnewswire.com
MIST
ESLT
Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT
globenewswire.com
MIST
Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
globenewswire.com
MIST
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MIST
Milestone Pharmaceuticals Announces that CARDAMYST™ (etripamil) Nasal Spray is Available on Express Scripts Commercial National Formularies
globenewswire.com
MIST
Form 8-K
sec.gov
MIST
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Update on the Commercial Launch of CARDAMYST™ (etripamil) Nasal Spray for the Treatment of PSVT
globenewswire.com
MIST
BIC, SPIN MASTER, MISTRAS GROUP TO LEAD AT 2026 AMERICAS EDITION OF BREAK THE CEILING TOUCH THE SKY® ON APRIL 20, 2026.
prnewswire.com
MIST
SPNS
PETS
Milestone Pharmaceuticals to Present Data on CARDAMYST™ (etripamil) Nasal Spray at the 2026 American College of Cardiology Annual Scientific Session
globenewswire.com
MIST
Milestone Pharmaceuticals to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 20, 2026
globenewswire.com
MIST